Moderator: Peter Kaiser, MD  |  Panelists: Jason Slakter, MD; Seenu Hariprasad, MD; Atul Jain, MD; Justis Ehlers, MD
Supported through an unrestricted educational grant from Regeneron Pharmaceuticals
Presented by:

PLAY ALL Diagnosis and treatment of macular degeneration CNV types Imaging types Hyperacuity testing Drug treatments Dosing regimens Comparison studies Safety issues OCT Patient response after switching to Eylea Why is Eylea more effective?